SCHEMBL853983

SCHEMBL853983

CCOC(=O)CC(c1cnc2ccccc2c1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.35
ITGAV P06756 1/20 0.35
CCKBR P32239 1/20 0.34
MTNR1A P48039 4/20 0.33
MTNR1B P49286 4/20 0.33
MGAM O43451 2/20 0.32
GAA P10253 2/20 0.32
SI P14410 2/20 0.32
MGAM2 Q2M2H8 2/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
CYSLTR2 Q9NS75 1/20 0.32
CYSLTR1 Q9Y271 1/20 0.32
PDE4D Q08499 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853670 0.92 NR1H2 (0.36) ITGB3ITGAVMTNR1AMTNR1BMGAM
SCHEMBL852713 0.84 ITGB3 (0.44) ITGB3ITGAVCCKBRMTNR1AMTNR1B
SCHEMBL853770 0.82 NR1H2 (0.36) ITGB3ITGAVMTNR1AMTNR1BMGAM
SCHEMBL854495 0.80 CCKBR (0.35) CCKBRMTNR1AMTNR1BTRPM8GABRA1
SCHEMBL861638 0.80 ITGB3 (0.51) ITGB3ITGAV
SCHEMBL852838 0.76 ITGB3 (0.51) ITGB3ITGAVMTNR1AMTNR1B
SCHEMBL853915 0.76 HTT (0.35) MTNR1AMTNR1BTRPM8KMT2AMEN1
SCHEMBL853781 0.75 ITGB3 (0.51) ITGB3ITGAVMTNR1AMTNR1BTRPM8
SCHEMBL854038 0.73 ITGB3 (0.48) ITGB3ITGAV
SCHEMBL861190 0.71 MAOA (0.42) ITGB3ITGAVMTNR1AMTNR1BNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed